Wauthoz N - Search Results

1

New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis.

Duret C, Wauthoz N, Sebti T, Vanderbist F, Amighi K. Duret C, et al. Among authors: wauthoz n. Int J Nanomedicine. 2012;7:5475-89. doi: 10.2147/IJN.S34091. Epub 2012 Oct 18. Int J Nanomedicine. 2012. PMID: 23093903 Free PMC article.

2

Nano-emulsions of fluorinated trityl radicals as sensors for EPR oximetry.

Charlier N, Driesschaert B, Wauthoz N, Beghein N, Préat V, Amighi K, Marchand-Brynaert J, Gallez B. Charlier N, et al. Among authors: wauthoz n. J Magn Reson. 2009 Apr;197(2):176-80. doi: 10.1016/j.jmr.2008.12.013. Epub 2008 Dec 24. J Magn Reson. 2009. PMID: 19128993

3

In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy.

Wauthoz N, Deleuze P, Hecq J, Roland I, Saussez S, Adanja I, Debeir O, Decaestecker C, Mathieu V, Kiss R, Amighi K. Wauthoz N, et al. Eur J Pharm Sci. 2010 Mar 18;39(5):402-11. doi: 10.1016/j.ejps.2010.01.010. Epub 2010 Jan 25. Eur J Pharm Sci. 2010. PMID: 20109545

4

Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment.

Wauthoz N, Deleuze P, Saumet A, Duret C, Kiss R, Amighi K. Wauthoz N, et al. Pharm Res. 2011 Apr;28(4):762-75. doi: 10.1007/s11095-010-0329-x. Epub 2010 Nov 30. Pharm Res. 2011. PMID: 21116692

5

Lactose characteristics and the generation of the aerosol.

Pilcer G, Wauthoz N, Amighi K. Pilcer G, et al. Among authors: wauthoz n. Adv Drug Deliv Rev. 2012 Mar 15;64(3):233-56. doi: 10.1016/j.addr.2011.05.003. Epub 2011 May 13. Adv Drug Deliv Rev. 2012. PMID: 21616107 Review.

6

Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca2+ release.

Lamoral-Theys D, Wauthoz N, Heffeter P, Mathieu V, Jungwirth U, Lefranc F, Nève J, Dubois J, Dufrasne F, Amighi K, Berger W, Gailly P, Kiss R. Lamoral-Theys D, et al. Among authors: wauthoz n. J Cell Mol Med. 2012 Jul;16(7):1421-34. doi: 10.1111/j.1582-4934.2011.01403.x. J Cell Mol Med. 2012. PMID: 21810170 Free PMC article.

7

Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.

Duret C, Wauthoz N, Sebti T, Vanderbist F, Amighi K. Duret C, et al. Among authors: wauthoz n. Int J Pharm. 2012 May 30;428(1-2):103-13. doi: 10.1016/j.ijpharm.2012.03.002. Epub 2012 Mar 10. Int J Pharm. 2012. PMID: 22414388

8

In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice.

Duret C, Wauthoz N, Merlos R, Goole J, Maris C, Roland I, Sebti T, Vanderbist F, Amighi K. Duret C, et al. Among authors: wauthoz n. Eur J Pharm Biopharm. 2012 Aug;81(3):627-34. doi: 10.1016/j.ejpb.2012.04.004. Epub 2012 Apr 20. Eur J Pharm Biopharm. 2012. PMID: 22538097

9

New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis.

Duret C, Wauthoz N, Sebti T, Vanderbist F, Amighi K. Duret C, et al. Among authors: wauthoz n. Pharm Res. 2012 Oct;29(10):2845-59. doi: 10.1007/s11095-012-0779-4. Epub 2012 May 30. Pharm Res. 2012. PMID: 22644590

10

Synthesis and plasma pharmacokinetics in CD-1 mice of a 18β-glycyrrhetinic acid derivative displaying anti-cancer activity.

Lallemand B, Ouedraogo M, Wauthoz N, Lamkami T, Mathieu V, Jabin I, Amighi K, Kiss R, Dubois J, Goole J. Lallemand B, et al. Among authors: wauthoz n. J Pharm Pharmacol. 2013 Mar;65(3):402-10. doi: 10.1111/j.2042-7158.2012.01603.x. Epub 2012 Nov 16. J Pharm Pharmacol. 2013. PMID: 23356849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page